
Appointments of Kevin Ostrander to Main Enterprise Officer and Dr. Niraj Vasisht to Main Engineering Officer Further Improve Management Staff


GRAND RAPIDS, Mich., Feb. 9, 2023 /PRNewswire/ — Corium Pharma Remedies, Inc. (CPSI), a major, total-service agreement enhancement and manufacturing group specializing in novel drug supply technologies for prescription drug and client solutions like transdermal modalities, has named Kevin Ostrander as Main Small business Officer and Dr. Niraj Vasisht as Main Technological innovation Officer. These appointments, which include CPSI’s current announcement that Mark Sirgo experienced been named Chief Executive Officer, additional improve CPSI’s government staff and place the enterprise for extended-time period development.


Appointments of Kevin Ostrander to Main Small business Officer and Dr. Niraj Vasisht to Chief Technologies Officer


Kevin Ostrander delivers additional than 30 years of practical experience as the two a research scientist and small business development qualified in the pharmaceutical field, obtaining labored for several little to mid-sized brand and generic companies. Prior to becoming a member of CPSI, Mr. Ostrander served as Vice President of Business enterprise Development for ApiJect Units, a privately held healthcare device business with proprietary delivery engineering in the sterile injectables sector. Before ApiJect, Kevin was Senior Vice President of Organization Enhancement at BioDelivery Sciences Intercontinental (BDSI) in which he was dependable for concluding the acquisition of the firm by Collegium Pharmaceutical. Mr. Ostrander retains a BS degree in Biology from the State College of New York at Albany, an MS diploma in Pharmaceutical High-quality Assurance and Regulatory Affairs from Temple College College of Pharmacy and an MBA in Intercontinental Organization from St. Joseph’s University.


“Owning worked together at BDSI, I am fired up to crew up with Kevin once more and I know he will perform an instrumental role in shaping our long-phrase advancement strategy,” said Mark Sirgo, CEO of CPSI. “Operating intently with myself, associates of the leadership staff and our buyers, we will concentration on leveraging our current abilities and pinpointing opportunity complimentary acquisitions that will make it possible for us to extend our footprint in the specialty contract manufacturing place.”


Dr. Niraj Vasisht brings a lot more than 25 many years of knowledge as an government, entrepreneur, and technological know-how critical-belief-chief in drug delivery to the pharmaceutical business. Prior to joining CPSI, Dr. Vasisht was President and CEO of Avior Bio, Inc., a clinical-phase, production-integrated pharmaceutical enterprise that was employing drug shipping and delivery to reinvent demonstrated therapeutics for scarce illnesses. Just before Avior, he was the Main Know-how Officer at BDSI wherever he invested 13 decades in multiple roles and oversaw the growth, acceptance, intellectual home creation and production of a few Fda approved solutions utilizing a novel drug shipping and delivery platform. Dr. Vasisht gained a bachelor’s in Chemical Engineering from the Indian Institute of Technological innovation, India, and a Doctorate in Chemical Engineering from Rensselaer Polytechnic Institute. He has about 25 patents, various publications and authored a book on Microencapsulation and Managed Launch.


Mr. Sirgo commented, “I worked closely with Niraj for numerous years at BDSI and am thrilled to have the option to lover with him yet again. As Chief Technology Officer, Niraj will enjoy a significant part overseeing the formulation enhancement perform powering all of our CPSI platforms. In addition, he will be primary the evaluation of complimentary platforms for potential acquisition that will allow CPSI to maintain a leadership role in the specialty enhancement and manufacturing sector.”


Founded in 1995 in Grand Rapids, Michigan, Corium Pharma Methods has maintained longstanding partnerships with multinational Fortune 500 corporations and pharmaceutical businesses alike. CPSI currently manufactures a range of more than the counter and prescription goods, which includes Proctor & Gamble Co’s (NYSE: PG) total Crest Whitestrips franchise, Agile Therapeutics, Inc.’s (NASDAQ: AGRX) Twirla®, and Corium, LLC’s (“Corium”) ADLARITY®, a the moment-weekly, transdermal donepezil patch for Alzheimer’s clients.


About Corium Pharma Methods


Headquartered in Grand Rapids, Michigan, Corium Pharma Solutions is a main, total-support deal advancement and producing corporation specializing in novel drug and customer product supply systems. With a observe file spanning just about 30 many years, the enterprise presents finish-to-conclude remedies to its partners, from formulation and product or service progress work, by way of business-scale producing and packaging. The firm’s achievement is enabled by its condition-of-the-art facilities, extremely tenured operational management, and proprietary drug delivery systems, CORPLEX™ and MICROCOR®. Corium Pharma Remedies is jointly owned by B-FLEXION and Webster Fairness Partners. Prior to the CPSI transaction with Webster Fairness Partners in Oct 2022, Gurnet Level Capital, an affiliate of B-Flexion, led the unique financial investment in Corium Pharma Options as a result of a consider-private transaction in October 2018.


About Gurnet Place Funds & B-FLEXION


Gurnet Place Funds, an affiliate of B-FLEXION, is a leading healthcare fund that invests in de-risked lifestyle sciences corporations. Gurnet Stage generally focuses on enterprises that have substantial advancement possible in the late product or service growth and commercialization levels of their evolution. These businesses come to be associates not just simply because of their ability to deliver financial value, but also due to the fact of their prospective to supply social impression. Gurnet Point’s crew of very professional marketplace executives performs intently with its portfolio businesses, with an lively tactic driving operational transformation and outsized returns.

www.gurnetpointcapital.com/


B-FLEXION is a non-public, entrepreneurial investment decision company, partnering with complex money to satisfy the shared goal of offering exceptional worth more than the generations, even though also contributing positively to modern society. The corporation oversees growth-oriented operating firms and asset supervisors, normally with an ‘active owner’ philosophy. B-FLEXION invests across a large range of industries, including healthcare. Gurnet Level Money, an affiliate of B-FLEXION, qualified prospects B-FLEXION’s de-risked existence sciences expense tactic.

https://www.bflexion.com/


About Webster Equity Partners


Established in 2003, Webster is a private equity firm that focuses on higher effects progress methods that seek to provide exceptional outcomes for our investors, portfolio organizations and the communities that we provide. Our mission is to provide exceptional returns to our associates by way of the financial commitment in and improvement of purpose driven affected person-centric health care companies committed to supplying very best of class clinical care and company to their patients. https://websterequitypartners.com/


Call


Gartman PR

(202) 413-4226


Watch unique material:https://www.prnewswire.com/news-releases/corium-pharma-answers-names-two-market-veterans-to-its-govt-group-301742673.html


Supply Corium Pharma Alternatives Inc.



